Bleximenib in Combination with Intensive Chemotherapy: A phase 1b Study in Patients with Newly Diagnosed Acute Myeloid Leukemia with KMT2A or NPM1 Alterations

Dohner H., Schuh AC., Recher C., O'nions J., Aldoss I., Pierola AA., Allred AJ., Alonso-Dominguez JM., Barreyro L., Bories P., Daskalakis N., Della Porta MG., D'souza A., Dugan J., Esteve J., Fathi AT., Ferrante L., Gaj S., Garciaz S., Diaz AG., Salamero O., Guttke C., Gyan E., Hiebert B., Jabbour E., Jentzsch M., Kantarjian HM., Konopleva M., Kronke J., Hutter-Kronke ML., Loefgren C., Lomas O., Mancini V., Mantzaris I., Morillo D., Packman K., Papayannidis C., Philippar U., Platzbecker U., Paniagua SG., Sackey N., Sauer T., Shastri PN., Searle E., Tovar N., Trancucci D., Vallet N., Vaughan L., Vyas P., Wei AH., Rolling C.

Type

Journal article

Publication Date

2026-01-01T00:00:00+00:00

Volume

32

Permalink Close